Xenon Pharmaceuticals, Inc. (XENE)
56.85
+0.16
(+0.28%)
USD |
NASDAQ |
Apr 02, 16:00
56.89
+0.04
(+0.07%)
Pre-Market: 20:00
Xenon Pharmaceuticals EPS Diluted (Quarterly) : -1.314 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 1.526 |
| Oncolytics Biotech, Inc. | -0.0139 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0746 |
| ProMIS Neurosciences, Inc. | -4.959 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -105.26M |
| Total Expenses (Quarterly) | 105.26M |
| Enterprise Value | 4.884B |
| Earnings Yield | -7.64% |
| Normalized Earnings Yield | -7.643 |